Cervical cancer is the second most common cancer in women. Standard treatment options
available for cervical cancer include chemotherapy, surgery and radiation therapy associated with
their own side effects and toxicities. Tumor-targeted delivery of anticancer drugs is perhaps one of
the most appropriate strategies to achieve optimal outcomes from the treatment and improve the
quality of life. Recently nanocarriers based drug delivery systems owing to their unique properties
have been extensively investigated for anticancer drug delivery. In addition to that addressing the
anatomical significance of cervical cancer, various local drug delivery strategies for the cancer
treatment are introduced like: gels, nanoparticles, polymeric films, rods and wafers, lipid based
nanocarrier. Localized drug delivery systems allow passive drug targeting results in high drug concentration
at the target site. Further they can be tailor made to achieve both sustained and controlled
release behavior, substantially improving therapeutic outcomes and minimizing side effects. This
review summarizes the meaningful advances in drug delivery strategies to treat cervical cancer.
Current status and future of delivery systems for prevention and treatment of infections in the oral cavity
